Clinical trials recruiting for Immune Checkpoint Inhibitors
4
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Phase 3 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Immunotherapy | 1 |
| Sintilimab | 1 |
| Zilongjin tablet combined with immunotherapy | 1 |
Self-screener
Recruiting trials
- Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC
- Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
- The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)
- The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer
Related conditions
Trials recruiting for Immune Checkpoint Inhibitors often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Non-small cell lung cancer 507Cancer, Treatment-Related 4Sleep Disturbance 23Psychological Stress 7Electroacupuncture 11Adjuvant Therapy 8
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Immune Checkpoint Inhibitors trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.